Published in J Neurooncol on August 21, 2010
Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series. J Neurooncol (2012) 1.00
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J Neurooncol (2011) 0.98
Intraparenchymal papillary meningioma of brainstem: case report and literature review. World J Surg Oncol (2012) 0.92
Radiosurgery with photons or protons for benign and malignant tumours of the skull base: a review. Radiat Oncol (2012) 0.89
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg (2015) 0.86
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model. Neuro Oncol (2013) 0.78
Treatment-related secondary cancer in malignant meningiomas: a population-based study. J Cancer Res Clin Oncol (2014) 0.76
PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget (2015) 0.75
Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. Neuro Oncol (2015) 0.75
Papillary meningioma of the jugular foramen: A case report. Oncol Lett (2015) 0.75
Systematic Analysis of Outcomes for Surgical Resection and Radiotherapy in Patients with Papillary Meningioma. J Neurol Surg B Skull Base (2015) 0.75
Imaging characteristics and surgical treatment of invasive meningioma. Oncol Lett (2017) 0.75
Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center. Medicine (Baltimore) (2017) 0.75
Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol (2017) 0.75
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature (2009) 5.48
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science (2007) 3.70
The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet (2013) 2.89
A secreted PTEN phosphatase that enters cells to alter signaling and survival. Science (2013) 2.86
Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci (2006) 2.43
Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery (2008) 2.33
The role of myosin II in glioma invasion of the brain. Mol Biol Cell (2008) 2.20
The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg (2013) 2.01
Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis. Glia (2006) 1.83
Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther (2007) 1.80
Glioblastoma models reveal the connection between adult glial progenitors and the proneural phenotype. PLoS One (2011) 1.77
Delayed surgical resection of central nervous system germ cell tumors. Neurosurgery (2002) 1.57
Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol (2009) 1.56
Epithelioid pituicytoma. World Neurosurg (2011) 1.39
Astrocyte elevated gene-1: a novel target for human glioma therapy. Mol Cancer Ther (2010) 1.39
Constitutive EGFR signaling in oligodendrocyte progenitors leads to diffuse hyperplasia in postnatal white matter. J Neurosci (2008) 1.38
Astrocytic regulation of human monocytic/microglial activation. J Immunol (2008) 1.32
Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol (2004) 1.30
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol (2013) 1.25
Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny. Neurosurgery (2010) 1.19
Primitive neuroectodermal tumors of the spine: a comprehensive review with illustrative clinical cases. Neurosurg Focus (2011) 1.18
A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One (2012) 1.15
Metastases to the pineal gland. Neurology (2006) 1.15
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan. Neurosurgery (2011) 1.14
Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia (2010) 1.14
Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors. Clin Cancer Res (2006) 1.12
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) (2009) 1.11
The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J Immunol (2009) 1.11
Dynamics of central and peripheral immunomodulation in a murine glioma model. BMC Immunol (2009) 1.11
Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary (2008) 1.11
Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly. J Clin Endocrinol Metab (2008) 1.07
Meningiomas of the velum interpositum: surgical considerations. Neurosurg Focus (2003) 1.07
The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn (2012) 1.02
Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma. J Immunol (2008) 1.01
Approaches to anterior and anterolateral foramen magnum lesions: A critical review. J Craniovertebr Junction Spine (2010) 1.00
Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res (2006) 1.00
Tumor-associated macrophages in glioma: friend or foe? J Oncol (2013) 1.00
Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy. J Neurooncol (2010) 0.99
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor. Pituitary (2011) 0.98
Surgical management of craniopharyngiomas. J Neurooncol (2009) 0.98
Motor deficits correlate with resting state motor network connectivity in patients with brain tumours. Brain (2012) 0.97
Direct inhibition of myosin II effectively blocks glioma invasion in the presence of multiple motogens. Mol Biol Cell (2012) 0.97
Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas. Neurosurgery (2006) 0.95
Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro. Clin Immunol (2002) 0.95
Simultaneous above and below approach to giant pituitary adenomas: surgical strategies and long-term follow-up. Pituitary (2009) 0.94
Production of 2-hydroxyglutarate by isocitrate dehydrogenase 1-mutated gliomas: an evolutionary alternative to the Warburg shift? Neuro Oncol (2011) 0.94
Incidence, cost, and mortality associated with hospital-acquired conditions after resection of cranial neoplasms. Neurosurgery (2014) 0.94
Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas. Neurosurgery (2007) 0.93
E2F1 coregulates cell cycle genes and chromatin components during the transition of oligodendrocyte progenitors from proliferation to differentiation. J Neurosci (2014) 0.92
Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol (2007) 0.91
Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly. Pituitary (2003) 0.91
Murine cell line model of proneural glioma for evaluation of anti-tumor therapies. J Neurooncol (2013) 0.91
Cytochrome c oxidase deficiency due to a novel SCO2 mutation mimics Werdnig-Hoffmann disease. Arch Neurol (2002) 0.91
Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pump. Neuro Oncol (2011) 0.90
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Hum Mol Genet (2012) 0.90
The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma. Neurol Res (2012) 0.90
Pre-operative intracranial meningioma embolization. Expert Rev Neurother (2011) 0.90
Transient cerebral hypoperfusion enhances intraarterial carmustine deposition into brain tissue. J Neurooncol (2007) 0.89
Medulloblasoma: challenges for effective immunotherapy. J Neurooncol (2011) 0.88
Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients. J Neurooncol (2009) 0.88
MDA-9/syntenin is a key regulator of glioma pathogenesis. Neuro Oncol (2013) 0.88
Evoked potential monitoring identifies possible neurological injury during positioning for craniotomy. Anesth Analg (2009) 0.88
Convection-enhanced delivery of topotecan into a PDGF-driven model of glioblastoma prolongs survival and ablates both tumor-initiating cells and recruited glial progenitors. Cancer Res (2011) 0.88
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells. Neuro Oncol (2013) 0.87
Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue. J Neurooncol (2014) 0.86
Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. J Neurosurg Pediatr (2012) 0.86
Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide. Mol Cancer Ther (2006) 0.86
A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery. J Clin Neurosci (2012) 0.86
Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. J Clin Neurosci (2012) 0.85
Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk. J Clin Endocrinol Metab (2014) 0.84
Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol (2012) 0.84
Glial progenitor cell recruitment drives aggressive glioma growth: mathematical and experimental modelling. J R Soc Interface (2012) 0.84
Tamoxifen paradoxically decreases paclitaxel deposition into cerebrospinal fluid of brain tumor patients. J Neurooncol (2006) 0.84
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series. Neurosurgery (2014) 0.84
Surgical approaches to the pineal region. Neurosurg Clin N Am (2011) 0.83
Surgical approaches to posterior third ventricular tumors. Neurosurg Clin N Am (2003) 0.83
The survival impact of postoperative infection in patients with glioblastoma multiforme. Neurosurgery (2009) 0.82
Synthesis and in vitro evaluation of [18F](R)-FEPAQ: a potential PET ligand for VEGFR2. Bioorg Med Chem Lett (2012) 0.82
Optic nerve glioma: case series with review of clinical, radiologic, molecular, and histopathologic characteristics. Ophthal Plast Reconstr Surg (2014) 0.82
Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma. Neuro Oncol (2013) 0.82